Protagenic Therapeutics, Inc.new PTIX Cash Flow Statement (2009-2026)

OTC PTIX
$0.47 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Protagenic Therapeutics, Inc.new Quarterly Cash Flow Statement

Periods 65 quarters
Latest Sep 2026

Protagenic Therapeutics, Inc.new reported cash from operations of -$0.49M and free cash flow of -$0.49M for the quarter ended Sep 2026, up 65.0% year over year. This cash flow statement covers 65 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-0.89M-1.36M-0.67M-0.93M-0.60M-0.72M-1.21M-1.40M-1.68M-1.72M-0.32M-0.58M-0.85M-1.44M-5.06M-0.87M2.21M5.08M-0.96M-0.67M
Depreciation and DepletionDep. & Depletion
90.0091.000.00M0.03M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.05M0.03M0.03M0.03M0.03M0.02M0.03M0.03M0.01M0.24M1.32M
Depreciation & Amortization (CF)Dep. & Amort.
90.0091.000.00M0.03M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M
Share-based CompensationStock Comp.
0.22M0.24M0.22M0.21M0.20M0.17M0.17M0.17M0.17M0.16M0.27M0.25M0.25M0.24M0.13M0.11M0.10M0.09M0.07M0.06M
Deferred Taxes
Gains from Equity InvestmentsGains Equity
Gains from Investment SecuritiesGains Investment
0.00M-0.02M-0.01M-0.01M0.00M-0.12M-0.02M-0.48M0.03M-0.34M
Asset Writedowns and ImpairmentWritedown
0.01M
Other non-cash itemsOther Non-Cash
-0.02M2.13M-0.20M-3.11M0.79M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
57.00-20.00-1.00-10.00
Change in Account PayablesChange Payables
0.27M-0.44M0.39M0.83M0.05M0.07M
Change in Accrued ExpensesChange Accrued Exp.
0.10M-0.01M-0.32M0.09M0.15M0.11M0.12M-0.11M-0.30M-0.21M0.35M0.11M0.22M0.17M0.26M-0.10M-0.16M0.01M-0.01M0.01M
Change in TaxesChange Taxes
-0.03M0.05M0.00M0.01M
Change in Other Operating AssetsOther Assets Change
-0.11M-0.68M0.13M-0.04M-0.04M-0.04M0.86M-0.77M0.04M-0.10M0.40M-0.08M-0.32M0.01M0.07M-0.10M-0.05M-0.02M0.11M-0.03M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.11M0.04M0.01M0.02M-0.04M
Other Working Capital ChangesOther WC Changes
0.11M0.68M-0.13M0.04M0.04M0.04M-0.86M0.66M0.00M0.10M-0.40M0.08M0.34M-0.05M-0.07M0.10M0.05M0.02M-0.11M0.03M
Cash from OperationsCash from Ops.
-0.41M-0.43M-0.85M-0.54M-0.18M-0.37M-1.53M-0.66M-1.14M-1.66M-1.55M-0.19M-0.82M-1.07M-1.75M-1.40M0.07M0.27M-0.94M-0.49M
Investing Activities
Capital ExpendituresCapex
0.09M
Change in Property, Plant and EquipmentChange in PP&E
-0.09M
Acquisitions
-0.94M
Net of Acquisitions & DivestmentsNet Acquisitions
0.94M
Purchase of InvestmentsInvestments Purchased
-0.07M2.75M0.30M
Sale and Maturity of InvestmentsInvestments Sold
0.37M0.71M0.46M0.09M0.29M1.61M0.66M5.12M1.50M1.60M
Cash from Investing ActivitiesCash from Investing
0.49M0.37M0.71M0.36M0.16M0.29M1.61M0.59M2.28M1.20M1.60M0.94M-0.31M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.87M0.08M-0.02M
Long-Term Debt RepaymentsLT Debt Repayment
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.87M0.08M-0.02M
Short-Term Debt issuancesST Debt Issuance
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
0.87M0.08M-0.02M
Change in Capital Stock
Common Stock IssuedStock Issued
10.84M0.32M1.60M0.10M4.35M2.00-2.00
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
10.84M0.32M1.60M0.10M4.35M2.00-2.00
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
10.84M0.32M1.60M0.10M4.35M2.00-2.00
Other financing activities (as filed)
Cash from Financing ActivitiesCash from Financing
0.32M1.60M0.10M5.01M-0.02M-0.58M-0.53M
Additional items
Exchange Rate EffectFX Effect
199.00806.000.00M0.00M0.08M467.00671.000.00M920.00190.00167.00-89.00399.00-11.00-0.12M0.04M-136.00-0.12M0.00M-187.00
Change in Cash
0.08M-0.06M-0.14M-0.18M0.06M-0.08M0.08M-0.07M1.13M-0.46M0.09M0.13M0.78M-0.97M4.20M-1.41M-0.51M-0.58M-0.94M-0.49M
Ending Cash Balance
0.54M0.48M0.34M0.16M0.22M0.14M0.22M0.15M1.29M0.00M0.92M0.07M0.08M0.01M4.10M2.72M2.21M1.51M0.57M0.08M
Free Cash FlowFCF
-0.41M-0.43M-0.85M-0.54M-0.18M-0.37M-1.53M-0.66M-1.24M-1.66M-1.55M-0.19M-0.82M-1.07M-1.75M-1.40M0.07M0.27M-0.94M-0.49M
Net Cash FlowNCF
0.08M-0.06M-0.14M-0.18M-0.02M-0.08M0.08M-0.07M1.13M-0.46M0.05M0.13M0.78M-0.97M4.20M-1.41M-0.51M-0.58M-0.94M-0.49M
Interest Paid
Income Taxes PaidTaxes Paid

Protagenic Therapeutics, Inc.new Cash Flow Statement API

Pull Protagenic Therapeutics, Inc.new's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PTIX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY